PC
ACIU icon

PA Capital’s AC Immune ACIU Stock Holding History

PA Capital’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$309K Buy
+63,263
New +$454K 0.22% 137
2020
Q2 		– Sell
-73,344
Closed -$507K – 169
2020
Q1 		$507K Buy
+73,344
New +$573K 0.45% 85
2019
Q4 		– Sell
-76,257
Closed -$377K – 130
2019
Q3 		$377K Buy
+76,257
New +$409K 0.37% 90
2019
Q2 		– Sell
-40,055
Closed -$202K – 108
2019
Q1 		$202K Buy
+40,055
New +$255K 0.18% 104

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PA Capital's ACIU Position: Q3 2020 in Review

PA Capital opened a new position in AC Immune (ACIU) in Q3 2020: 63,263 shares worth $309K. The stake represents 0.22% of the portfolio and ranks #137 among its holdings. This is a return to the name: PA Capital previously reported a position in ACIU as recently as Q1 2020.

PA Capital first reported a position in ACIU in Q1 2019 and has held it in 4 quarters since. The position peaked at $507K in Q1 2020. 53 funds tracked by Wall St. Rank hold ACIU as of Q3 2020.

  • PA Capital held 63,263 shares of AC Immune worth $309K as of Q3 2020.
  • AC Immune was a new PA Capital position in Q3 2020.
  • AC Immune made up 0.22% of PA Capital's portfolio in Q3 2020, its #137 holding.
  • PA Capital first reported a position in AC Immune in Q1 2019 and has held it in 4 quarters since.
  • PA Capital's AC Immune position peaked at $507K in Q1 2020.
  • 53 funds tracked by Wall St. Rank held AC Immune as of Q3 2020.

Based on PA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.